跳到正文
原文
Nature 健康护理主题·· 28 天前AI 评分48

ACCESS2 研究:自主 AI 在减少青少年糖尿病视网膜病变筛查差异中的潜力

ACCESS2 study: the potential for autonomous AI to mitigate disparities in diabetic retinopathy screening in youth

AI 导读

一篇发表在 Nature Communications 的研究探讨了自主 AI 在减少青少年糖尿病视网膜病变筛查地区差异中的潜力。该研究由 Johns Hopkins 医学院儿科内分泌科团队主导,并得到美国国立卫生研究院(NIH)和 Breakthrough T1D 资助,数字诊断公司提供了自主 AI 解读支持。

正文

Acknowledgements

We thank the patients and their parents or guardians at the Johns Hopkins Pediatric Diabetes Center and Mount Washington Pediatric Hospital for their participation.

Funding

This clinical study was supported by the National Eye Institute of the National Institutes of Health under Award Number R01EY033233, and Breakthrough T1D (formerly JDRF) under Award number (2-SRA-2023-1306-M-B) to R.M.W. R.C. receives research support in part by an Unrestricted Grant from Research to Prevent Blindness, Inc. to the UW-Madison Department of Ophthalmology and Visual Sciences, and by the National Eye Institute of the National Institutes of Health under Award Number 5K23EY030911-03. T.Y.A.L. receives funding support from the Research to Prevent Blindness Career Development Award. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies. Digital Diagnostics provided autonomous AI interpretations in-kind; no other support was received from Digital Diagnostics. This manuscript is the result of funding in whole or in part by the National Institutes of Health (NIH). It is subject to the NIH Public Access Policy. Through acceptance of this federal funding, NIH has been given a right to make this manuscript publicly available in PubMed Central upon the Official Date of Publication, as defined by NIH.

Author information

Authors and Affiliations

  1. Department of Pediatric of Endocrinology, Johns Hopkins School of Medicine, Baltimore, MD, USA

    Risa M. Wolf, Elizabeth A. Brown, Lee Bromberger, Neha Parimi, Anum Zehra, Dhruva Patel, Bernard Pan, Yoohee Claire Kim & Aliyah Shehadeh

  2. Department of Ophthalmology and Visual Sciences, University of Wisconsin, Madison, WI, USA

    Roomasa Channa

  3. Wilmer Eye Institute, Johns Hopkins School of Medicine, Baltimore, MD, USA

    T. Y. Alvin Liu

  4. Section on Biomedical Informatics and Data Science, Johns Hopkins University, Baltimore, MD, USA

    Harold P. Lehmann

  5. Department of Ophthalmology and Visual Sciences, The University of Iowa, Iowa City, IA, USA

    Michael D. Abramoff

  6. Digital Diagnostics Inc, Coralville, IA, USA

    Michael D. Abramoff

  7. Iowa City VA Medical Center, Iowa City, IA, USA

    Michael D. Abramoff

  8. Department of Biomedical Engineering, The University of Iowa, Iowa City, IA, USA

    Michael D. Abramoff

  9. Department of Electrical and Computer Engineering, The University of Iowa, Iowa City, IA, USA

    Michael D. Abramoff

Authors

  1. Risa M. Wolf
  2. Roomasa Channa
  3. T. Y. Alvin Liu
  4. Elizabeth A. Brown
  5. Lee Bromberger
  6. Neha Parimi
  7. Anum Zehra
  8. Dhruva Patel
  9. Bernard Pan
  10. Yoohee Claire Kim
  11. Aliyah Shehadeh
  12. Harold P. Lehmann
  13. Michael D. Abramoff

Corresponding author

Correspondence to Risa M. Wolf.

Ethics declarations

Competing interests

M.D.A. reports the following conflicts of interest: Investor, Director, Consultant, Digital Diagnostics Inc., Coralville, Iowa, USA; patents and patent applications assigned to the University of Iowa and Digital Diagnostics that are relevant to the subject matter of this manuscript; Chair Healthcare AI Coalition, Washington DC; member, American Academy of Ophthalmology (AAO) AI Committee; member, AI Workgroup Digital Medicine Payment Advisory Group (DMPAG); member, Collaborative Community for Ophthalmic Imaging (CCOI), Washington DC; Chair, Foundational Principles of AI CCOI Workgroup. RMW reports receiving research support as the site PI of sponsored clinical trials by Novo Nordisk, Lilly Diabetes and Sanofi, and is a consultant for Sanofi and Mannkind, unrelated to this work. No other conflicts of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wolf, R.M., Channa, R., Liu, T.Y.A. et al. ACCESS2 study: the potential for autonomous AI to mitigate disparities in diabetic retinopathy screening in youth. Nat Commun (2026). https://doi.org/10.1038/s41467-026-78842-w

Download citation

  • Received: 12 September 2025

  • Accepted: 01 October 2026

  • Published: 23 October 2026

  • DOI: https://doi.org/10.1038/s41467-026-78842-w

来源:Nature 健康护理主题 · nature.com